• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, November 19, 2021

Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A piece by The Business Journals cited an article published in a supplement to The American Journal of Managed Care® (AJMC®). The article, “Utilizing Oncology Biosimilars to Minimize the Economic Burden Associated With Cancer Treatment: Managed Care Considerations,” discussed pharmacists’ role in providing consistent messaging about biosimilars to both health care professionals and patients with cancer.

A story by BestLife referenced a study published in a supplement to AJMC®, titled “The Economic Impact of Peanut Allergies.” The study addressed the direct and indirect costs related to peanut allergies, which affect an estimated 1.2% of the overall US population and about 2.5% of the pediatric population.

Related Videos
Dr Maria DeYoreo
Jade E. Jones, MD
Sabarish Ayyappan, MD
Gladys Antelo Allen
Debra Patt, MD, PhD, MBA, MPH
Gladys Antelo-Allen
Carrie Kozlowski, OT, MBA, Upfront Healthcare
Gladys Antelo-Allen
Robin Glasco, Spencer Stuart
Dr Cesar Davila-Chapa
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.